06.05.2014 Views

02 BOOK OF ABSTRACTS .indd

02 BOOK OF ABSTRACTS .indd

02 BOOK OF ABSTRACTS .indd

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Electrochemotherapy of cancer – therapeutic perspectives<br />

Gregor Ser{a for the ESOPE group<br />

Institute of Oncology, Zalo{ka 2, SI-1000 Ljubljana, Slovenia<br />

Electrochemotherapy consists of chemotherapy followed by local application of<br />

electric pulses to the tumour to increase drug delivery into cells. Drug uptake can<br />

be increased by electroporation for only those drugs whose transport through the<br />

plasma membrane is impeded. Among many drugs that have been tested so far,<br />

only bleomycin and cisplatin found their way from preclinical testing to clinical<br />

trials. In vitro studies demonstrated several fold increase of their cytotoxicity after<br />

electroporation of cells. In vivo, electroporation of tumours after local or systemic<br />

administration of either of the drugs, i.e. electrochemotherapy, proved to be an<br />

effective antitumour treatment<br />

Physico-chemical basis of this therapy allows prediction that electrochemotherapy<br />

has good antitumour effect on all tumour types, which was demonstrated in several<br />

clinical studies. The ESOPE clinical trial has demonstrated that an objective response<br />

rate of 85% (73.7% complete response rate) was achieved on the electrochemotherapy<br />

treated tumour nodules, regardless of tumour histology, and drug used or route of<br />

its administration.<br />

The clinical experience gained so far in the ESOPE project provided evidence that<br />

electrochemotherapy is successful treatment in various clinical indications:<br />

• Easy and effective treatment of single or multiple tumour nodules of any<br />

histology in the cutaneous and subcutaneous tissue.<br />

• Treatment that increases quality of life in patients with progressive disease.<br />

38l23<br />

• Treatment of choice for tumours refractory to conventional treatments.<br />

• Neoadjuvant treatment in form of cytoreductive therapy before conventional<br />

treatment.<br />

• Organ sparing and function saving treatment.<br />

• Treatment of hemorrhagic or painful nodules, since it reduces bleeding and in<br />

some cases pain level.<br />

All these indications provide electrochemotherapy broad spectrum of use, predominantly<br />

because electrochemotherapy is effective local therapy and additionally<br />

quick and easy to perform.<br />

• Ser{a G, Cema`ar M, Rudolf Z. Electrochemotherapy: advantages and drawbacks<br />

in treatment of cancer patients. Cancer Therapy 2003; 1: 133-42.<br />

• Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment<br />

using enhanced delivery of bleomycin by electroporation. Cancer Treat<br />

Rev 2003; 29: 371-87.<br />

The ESOPE (QLK3-20<strong>02</strong>-<strong>02</strong>003) study was supported by EU commission project, and<br />

Research Agency of Slovenia.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!